Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
In Re: Oxycontin Antitrust Litigation
Case Number:
1:04-md-01603
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Akin Gump
- Axinn Veltrop
- Berger Montague
- BoiesBattin
- Boies Schiller
- Cadwalader Wickersham
- Cafferty Clobes
- Cohen Milstein
- Covington & Burling
- Cozen O'Connor
- Crowell & Moring
- Day Pitney
- Dewsnup King
- Epstein Drangel
- Faruqi & Faruqi
- Finnegan
- Fish & Richardson
- Foote Mielke
- Frost Brown
- Gardy & Notis
- Giaccio LLC
- Goldman Gruder
- Goodwin Procter
- Hagens Berman
- Henrichsen Law Group
- Hunton Andrews
- Jones Day
- Joseph Saveri Law Firm
- Kaplan Fox
- Keker Van Nest & Peters
- Kenny Nachwalter
- Kenyon & Kenyon
- King & Spalding
- Kirby McInerney
- Klehr Harrison
- Labaton Keller
- Law Offices of Curtis V. Trinko
- Locke Lord
- Lowenstein Sandler
- Lowey Dannenberg
- Lowther Johnson
- Markus & Sheridan
- McDonald Hopkins
- Morrison Foerster
- Morrison Mahoney
- Motley Rice
- Murray Law Firm
- Odom & Des Roches
- Paul Weiss
- Pearson Warshaw
- Pomerantz LLP
- Porter Wright
- Pugh Jones
- Rakoczy Molino
- Robins Kaplan
- Ropes & Gray
- Schnader Harrison
- Shuman Glenn
- Taus Cebulash
- Venable LLP
- Wilk Auslander
- Wolf Haldenstein
- Wolf Popper
- Zwerling Schachter
Companies
- Abbott Laboratories
- Aetna Inc.
- Allergan PLC
- Boehringer Ingelheim
- Boehringer Ingelheim Vetmedica Inc.
- Humana Inc.
- Impax Laboratories, Inc.
- KVK Tech Inc.
- KV Pharmaceutical Co.
- Medica Health Plans Inc.
- Meijer Inc.
- Mylan NV
- Noramco Inc.
- PRA Health Sciences Inc.
- Purdue Pharma LP
- Rochester Drug Cooperative Inc.
- Teva Pharmaceutical Industries Ltd.
- The Kroger Co.
- United Federation of Teachers
- United Food & Commercial Workers International Union
- Winthrop University Hospital
Government Agencies
Sectors & Industries:
-
April 08, 2015
Purdue's Anti-Abuse OxyContin Patent Claims Found Invalid
A New York federal judge on Wednesday ruled that although Amneal Pharmaceuticals LLC infringed Purdue Pharma LP's patent with its generic version of an abuse-resistant variety of the pain medication OxyContin, Purdue's asserted claims are invalid as obvious and indefinite.
-
May 28, 2014
Judge Sends Abuse-Resistant OxyContin Patents To Trial
A New York federal judge on Tuesday issued a major claims construction ruling for two of Purdue Pharma LP's OxyContin patents that are designed to prevent abuse of the painkiller, clearing the way for a July bench trial with generic producers over whether the patents are valid.
-
January 14, 2014
Teva Didn't Infringe OxyContin Patents, NY Judge Rules
A New York federal judge on Tuesday found that Teva Pharmaceuticals USA Inc. did not infringe any valid Purdue Pharma LP patent when it attempted to sell a generic version of narcotic pain medication OxyContin.
-
September 25, 2013
Par, Purdue Settle IP Claims In OxyContin Antitrust MDL
Par Pharmaceutical Cos. Inc. has settled a suit alleging its proposed generic OxyContin infringed Purdue Pharma LP patents for a tamper-resistant form of the widely abused painkiller, according to a consent judgment Tuesday laying to rest claims that were rolled into antitrust multidistrict litigation in New York federal court.
-
September 23, 2013
Oxycontin Patents Not Infringed, Drug Cos. Say At Trial
Impax Laboratories Inc. and other drug makers said Monday that generic versions of Purdue Pharma LP’s OxyContin do not infringe Purdue-held patents, opening a patent trial that could help end Purdue’s monopoly on some formulations of the popular painkiller.
-
May 16, 2013
Purdue Puts Generic OxyContin Suits To Rest
Purdue Pharma LP on Thursday settled its suits against KVK-Tech Inc. and Varam Inc. in New York multidistrict litigation over plans to market a generic version of painkiller OxyContin.
-
May 18, 2011
CVS, Rite Aid Strike Deal In OxyContin MDL
CVS Pharmacy Inc., Rite Aid Corp. and other direct purchasers of OxyContin reached a settlement Tuesday with Purdue Pharma LP in multidistrict litigation in New York alleging the drugmaker filed bogus patent litigation to crush generic competition for the painkiller.
-
October 15, 2009
Kentucky AG Fights To Remand OxyContin Claims
Kentucky Attorney General Jack Conway has asked a federal judge to remand to state court a suit accusing Purdue Pharma LP of failing to warn about the risks associated with controversial painkiller OxyContin, arguing that the drugmaker improperly joined the suit with unrelated patent and antitrust actions.
-
September 02, 2008
Purdue Pharma Strikes Licensing Deal For OxyContin
Purdue Pharma LP and generics maker Mallinckrodt Inc. have struck a deal that will allow Mallinckrodt to market and sell its cheaper version of the brand-name painkiller OxyContin for a licensing fee.
-
January 08, 2008
Judge Finds Purdue's OxyContin Patents Enforceable
A New York federal judge has found that Purdue Pharma LP did not engage in conduct that invalidated its patents for OxyContin in a ruling that the drug company claims severely damages antitrust claims against it in consolidated litigation.